Company Profile
Cytogen, Inc., a biotechnology company provides blood cancer cell-based Liquid Biopsy application business in South Korea. The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips.
Its portfolio also includes IF stainers, automated immunofluorescent staining system, and cell image analyzers, which help captures immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies. The company sells its products under the Smart Biopsy brand name. Founded in 2010, Cytogen is headquartered in Seoul, South Korea.